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Urethral sphincter mechanism incompetence in spayed bitches:
new insights into the pathophysiology and options for treatment
Abstract
Incidence of USMI after ovariectomy Urinary incontinence is the involuntary loss of urine [1]. In intact
bitches urinary incontinence is rare (0-1 %) [2], whereas in spayed bitches the incidence is up to 20%
[3]. The underlying pathophysiological mechanism is mainly an acquired insuffi cient closure of the
urethra after spaying [4]. Therefore urinary incontinence after spaying is called urethral sphincter
mechanism incompetence (USMI). Within one year after spaying the urethral closure pressure is signifi
cantly reduced. Because many bitches may only become incontinent years after surgery it took a long
time until the causal relationship between ovariectomy and the occurrence of incontinence was proven
[5]. In one study, 83 of 412 (20%) bitches became incontinent 3 to 10 years after surgery [3]. As long as
40 years ago urinary incontinence was described as a rare side effect of spaying [6]. However, it took 20
years to verify the causal relationship between the removal of the ovaries and urinary incontinence [5].
The triggering mechanism is still unclear. Neuronal damage can most likely be disregarded, as the risk
of urinary incontinence is the same in ovariectomised and ovariohysterectomised bitches [3].
becoming continent [3, 11, 12]. Also, the plasma oestrogen 
concentration of spayed incontinent bitches is the same [13] or 
slightly lower [14] than that of intact, continent bitches.
Treatment of USMI
Dogs with USMI have a higher risk of urinary tract infection, 
that can result in polyuria and detrusor instability of the bladder. 
Urinary tract infection and other diseases causing polyuria 
such as decreased renal function, Cushing’s disease, diabetes 
mellitus, or corticosteroid treatment can lead to overt urinary 
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The role of oestrogen defi ciency
It is generally assumed that USMI after spaying is due to an 
oestrogen defi ciency [7, 8]. In view of other facts it appears 
unlikely that oestrogen defi ciency alone accounts for USMI after 
spaying. For example, bitches treated with long acting gestagens 
to suppress the sexual cycle, have no increased risk for urinary 
incontinence, although this treatment leads to suppressed 
ovarian function [9] with a serum oestradiol concentration 
remaining at a basal level [10]. In addition, daily supplement 
of oestrogen only results in 61-65% of incontinent bitches 
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incontinence in dogs with USMI. Thus urinary tract infection 
and polyuric diseases should always be ruled out or treated 
adequately.
Medical treatment of USMI
Medical treatment of USMI is the method of choice and should 
always precede surgical therapy. The aim of medical treatment 
is to increase the urethral closure pressure. 
Alpha-adrenergic drugs
In the fi rst line alpha-adrenergic agonists are used. The effect of 
these sympathomimetic drugs is explained by the fact that 50% 
of the urethral closure pressure is generated by the sympathetic 
nervous system. Alpha-adrenergic agonists improve the urethral 
closure pressure by stimulation of the alpha-receptors of the 
smooth urethral musculature [13, 15-19]. The treatment with 
alpha-adrenergic agonists results in continence in 75% of 
incontinent bitches.
The alpha-receptors are divided into alpha-1 and alpha-2 
subtypes. These receptor subtypes are distributed differently 
in each single effector. Alpha-1 receptors are found in many 
target organs of the sympathetic nervous system. With a few 
exceptions, alpha-2 receptors are not present in target organs 
of the sympathetic nervous system, but in neuronal synapses. 
It is now known, that the alpha-receptors at the bladder neck 
and proximal urethra of the bitch, which are responsible for 
continence, belong to the subtype 1 [20].
The side effects of alpha-adrenergic agonists is explained by the 
fact that alpha-1 receptors are not just found at the bladder 
neck, but also in other organs, especially in blood vessels. 
Phenylpropanolamine (PPA) acts selectively on alpha-1 receptors. 
The older substance Ephedrine is less selective than PPA. It also 
stimulates beta-receptors, and therefore has more side effects 
[21]. In contrast to PPA a habituation to Ephedrine occurs. 
Because of these reasons PPA is the therapy of fi rst choice [21].
In humans treatment with PPA sometimes causes side effects, 
such as an increase in blood pressure and headache. It may 
occasionally trigger a stroke or a heart attack and is therefore no 
longer used. When PPA was used in dogs at the recommended 
dose of 1.5 mg/kg BW bid or tid, an increase in blood pressure 
was not observed [18, 22]. The side effects observed in dogs were 
never life threatening and usually were self-limiting; diarrhoea, 
vomiting, anorexia, apathy, nervousness and aggression [3, 19, 
23].
Oestrogens
An alternative is the treatment with oestrogens, which is 
successful in 65% of the incontinent dogs [3, 12, 24]. However, 
with oestrogens unwanted side effects can occur such as 
swelling of the vulva and attraction of male dogs [12]. Nowadays 
only short-acting oestrogens (Estriol, Incurin®, Intervet, 
Netherlands) are used [11]. The depot preparations used in the 
past are obsolete, in part because they can potentially cause 
bone marrow depression [25]. Oestrogens indirectly increase 
the urethral closure pressure by sensitizing the alpha-receptors 
to endogenous and exogenous catecholamines [26]. If therapy 
with alpha-adrenergic agonists is unsatisfactory, a combination 
with oestrogens may potentiate the effect.
GnRH depot analogues
As mentioned before not all the observations can be explained 
by oestrogen defi ciency as being the sole underlying cause of 
urinary incontinence after spaying. In addition, it is not the only 
endocrine hormonal change after spaying. By removing the 
ovaries the feedback function of the gonadal hormones on the 
hypothalamic-pituitary system is abolished [27], which in turn 
results in a several fold increase of the initial plasma levels of 
the two gonadotropins (follicle stimulating hormone FSH, and 
luteinizing hormone, LH) [28, 29]. The question arises, if the 
elevated FSH and LH concentrations are responsible for the high 
incidence of urinary incontinence in spayed bitches. If this was 
the case suppression of the gonadotropin secretion would result 
in continence in affected bitches. GnRH depot preparations are 
suitable for the suppression of FSH and LH secretion. These 
are subcutaneously administered implants, which continuously 
secrete GnRH and, dependant on the preparation, result in an 
elevated blood concentration over weeks or months. This leads to 
a down-regulation of the GnRH-receptors in the pituitary gland 
and thereafter to a decrease of the FSH and LH concentrations 
to a low level.
Eighteen of thirtyfi ve bitches with USMI after spaying did indeed 
become continent, for an average period of 229 days [30, 31], 
after receiving depot preparations of GnRH-analogues. However, 
it is questionable if the therapeutic success is due to a decrease 
of the gonadotropin concentrations as there was no difference 
in concentrations between responders and non-responders [31]. 
It is possible that the success of the treatment is not based on a 
decrease in the FSH and LH, but instead on a direct effect of the 
GnRH on the lower urinary tract. This idea is quite conceivable 
as our working group has recently been able for the fi rst time to 
prove the presence of LH, FSH and also GnRH receptors in the 
bladder and urethra of bitches [32]. Apart from that, it has been 
shown that the effect of GnRH is not limited to the regulation 
of pituitary hormones, but GnRH is also produced outside the 
hypothalamus and may have a direct effect on the target organs 
[33].
The fact that GnRH, FSH and LH receptors are expressed in the 
lower urinary tract and other organs supports the assumption 
that GnRH performs specifi c functions in the tissue and that 
a widely distributed paracrine or autocrine regulatory system 
exists.
In about 50% of bitches with urinary incontinence treatment 
with GnRH-analogues was successful [30, 31]. Based on the 
proposed pathophysiology of USMI, that after spaying the 
decrease in urethral closure pressure is the underlying cause 
for urinary incontinence, it seems reasonable to assume 
that the therapeutic success is due to a normalization of the 
urethral sphincter mechanism. However, this hypothesis was 
clearly disproved by the recording of urethral pressure profi les 
of incontinent bitches before and after GnRH treatment. The 
application of GnRH had no signifi cant effect on the urodynamic 
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parameters, even in successfully treated bitches [31]. Recent 
studies in Beagle bitches may assume that GnRH modulates 
bladder function [34]. In 10 spayed Beagle bitches cystometric 
examinations were performed before and after treatment with 
depot formulations of GnRH analogues. The results showed a 
doubling of the difference between the medium and maximum 
bladder fi lling volume at the same bladder pressure after GnRH 
treatment.
Tricyclic antidepressant agents
Tricyclic antidepressant agents such as imipramine (0.5 to 1 mg/
kg tid per os) increase bladder capacity, along with the urethral 
sphincter closure pressure [35]. These drugs may be benefi cial 
to dogs with urinary incontinence due to USMI and detrusor 
instability or as postoperative treatment of USMI.
Surgical treatment of USMI
For refractory cases at least three different surgical therapies 
are available. However, before considering surgery, urinary tract 
infection should be ruled out or be initially treated. Polyuric 
diseases should also be evaluated and managed. Colposuspension 
[36], urethropexy [37] and endoscopic injection of collagen [38] 
are mainly used as surgical therapy, with a success rate of 50 – 
75%. With all three techniques a deterioration in the response 
rate was seen over time. At our clinic, we prefer the endoscopic 
injection of collagen as this method is least invasive with a 
minimal rate of complications, and the results are as good as 
the more invasive techniques [39].
Colposuspension [36]
The bitch is placed in dorsal recumbency with the hind limbs 
fl exed. A Foley catheter is used to empty the bladder. The 
catheter cuff is infl ated with air and drawn into the neck of the 
bladder. A caudal midline, abdominal skin incision is made. The 
prepubic tendon is exposed on both sides of the mid-line. The 
external pudendal vessels are identifi ed and avoided. Traction 
on the bladder allows the bladder neck to be identifi ed due to 
the presence of the infl ated Foley catheter cuff. An index fi nger 
is inserted through the vulva and used to displace the vagina 
cranially. The fat and fascia around the ventral bladder neck and 
proximal urethra are separated until the vaginal wall is exposed 
dorso-lateral to the urethra. The vaginal wall is grasped with Allis 
tissue forceps on each side of and approximately one centimetre 
away from the proximal urethra. The surgeon withdraws the 
fi nger from the vagina and changes his gloves. The vagina on 
each side of the proximal urethra is anchored to the prepubic 
tendon using two 0 or 1 monofi lament nylon sutures. Sutures 
are taken through the full thickness of the vaginal wall and are 
pre-placed. Before tying, tension is placed on the sutures to 
determine that strangulation of the urethra between the vagina 
and pubis would not occur. Once the sutures are tied, a fi nal 
examination is performed to confi rm that the urethra is freely 
moveable between the vagina and pubis and is not compressed 
in any way. The benefi cial effect of the operation may be the 
resultant re-location of the bladder, bladder neck and proximal 
urethra into an intra-abdominal position.
Urethropexy [37]
A caudal midline celiotomy is performed. Blunt dissection 
in the midline is used to visualise the ventral aspect of the 
urethra at the level of the cranial pubic brim. A suture of 2/0 
or 0 polypropylene is placed caudal to one prepubic tendon so 
that it enters the caudal abdomen. While traction is applied to 
the bladder neck and urethra via the bladder neck stay suture, 
the polypropylene suture is passed transversely through the 
muscular layers of the adjacent urethra. Once placed through 
the urethra, the suture is passed caudal to the opposite prepubic 
tendon and out of the abdominal cavity. The suture ends are 
held together with a pair of haemostatic forceps. The procedure 
is repeated, with a second polypropylene suture being placed 
through the urethral wall approximately 3 to 5 mm cranial to the 
fi rst. Both the polypropylene sutures are now tied. This results in 
the closure of the most caudal aspect of the celiotomy incision 
and fi xation of the urethra to the ventral abdominal wall at the 
end of the cranial pubic brim. The mechanism of action remains 
uncertain, although re-location of the bladder neck into an intra-
abdominal position and the production of a localised increase in 
urethral resistance are likely consequences of the procedure. 
Urethral submucosal injection of collagen [38]
The goal of treatment is to enhance the closure of the proximal 
urethra. For endoscopic injection of collagen the dogs are placed 
under general anesthesia and positioned in dorsal recumbency 
with the hind limbs extended cranially. A human cystoscope is 
passed into the urethra via the external orifi ce. Approximately 
1.5 cm caudal to the neck of the bladder, 3 injections of collagen 
are made into the submucosa at 2, 6 and 10 o’clock positions, 
respectively [38]. The procedure is considered complete when, 
on viewing through the cystoscope, the urethral lumen is closed 
by the collagen deposits. 
Comparison of the surgical techniques for USMI
With the collagen injection, incontinence initially resolved in 83 
% of 40 bitches, by injection alone in 68 % and with additional 
medication in the remaining 15 % [39]. Up to 12 months after 
the injection, there was a deterioration in the initial result in 
16 dogs, thereafter the results remained unchanged. Among 
these 16 dogs, 13 dogs were reclassifi ed from the continent 
group to one of the other 3 groups (continent with additional 
medication, incontinence improved by approximately 80 % after 
collagen injection and with additional medication, incontinence 
remained unchanged after collagen injection) up to 12 months 
after the injection. This corresponded to the period necessary 
for resorption of collagen deposits as seen in women [40]. 
However, the fact that the success rate categories stabilized 1 
year after treatment suggested that the collagen deposits are 
not resorbed in dogs. Also, histologic examinations of collagen 
deposits 12 months after injection in dogs revealed that they 
were still in place as cell-free masses surrounded by a connective 
tissue capsule [38]. Flattening of the deposits was likely the 
cause of reoccurrence of incontinence.
Collagen injections compare well to the other established 
surgical methods for the treatment of canine USMI. After 
urethropexy, 56 % of affected dogs were continent and 27 % 
had an improvement in continence [37]. A similar success rate 
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was observed after colposuspension, with 53 % of the female 
dogs continent and a further 38 % experiencing a marked 
improvement (41). However, a serious complication with both 
these techniques is an increased risk of urinary retention, a post-
operative condition not seen in dogs injected with collagen.
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